je.st
news
Tag: clinical
Boston Biomedical Announces Clinical Data Presentation Of Its Cancer Stem Cell Inhibitor Programs
2014-06-16 19:56:43| Logistics - Topix.net
Clinical data were presented for BBI608 and BBI503, novel agents targeting cancer stem cells that have been developed by the company.
Tags: data
cell
programs
presentation
Results of First Ever REMOTE Clinical Trial
2014-06-16 13:53:01| drugdiscoveryonline Home Page
Tags: results
trial
remote
clinical
Remote Monitoring of Clinical Source Data Why Not?
2014-06-09 19:37:22| drugdiscoveryonline Home Page
Date: Monday, July 28, 2013 Time: 1pm - 2:30pm EDT Duration: 90 Minutes - Online Price: $299 - Introductory Rate
FDA Removes Clinical Hold on Study of Pancreatic Cancer Drug
2014-06-08 05:12:05| Biotech - Topix.net
The FDA has removed its clinical hold on patient enrollment and dosing of PEGPH20 in an ongoing phase II trial evaluating the investigational compound in patients with pancreatic cancer, permitting the study to resume under a revised protocol.
Merck to Present New Clinical Data on JANUVIA (Sitagliptin), Investigational Omarigliptin, and Real-World Data in Patients with Type 2 Diabetes at the 74th Scientific Sessions of the American Diabetes Association
2014-06-06 14:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, will present 13 new studies and analyses, including data for its DPP-4 inhibitor JANUVIA (sitagliptin) and for its investigational once-weekly DPP-4 inhibitor omarigliptin, at the 74th Scientific Sessions of the American Diabetes Association (ADA) being held in San Francisco, June 13-17, 2014. Several analyses of patient data in real-world settings will also be presented. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558orKim Hamilton908-423-6831 or 908-391-0131orInvestor:Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] next »